BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1019 related articles for article (PubMed ID: 10131343)

  • 1. Survey of sterile product compounding practices in Canadian hospital pharmacies.
    Fitch DP; Hall KW
    Can J Hosp Pharm; 1993 Dec; 46(6):249-60. PubMed ID: 10131343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National survey of quality assurance activities for pharmacy-prepared sterile products in hospitals.
    Crawford SY; Narducci WA; Augustine SC
    Am J Hosp Pharm; 1991 Nov; 48(11):2398-413. PubMed ID: 1746573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compounding parenteral nutrition: reducing the risks.
    Curtis C; Sacks GS
    Nutr Clin Pract; 2009; 24(4):441-6. PubMed ID: 19605798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bulk compounding in Canadian hospitals--a survey.
    Taddio A; Wilson W
    Can J Hosp Pharm; 1990 Oct; 43(5):213-8, xxxii. PubMed ID: 10107923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. National survey of quality assurance activities for pharmacy-prepared sterile products in hospitals and home infusion facilities--1995.
    Santell JP; Kamalich RF
    Am J Health Syst Pharm; 1996 Nov; 53(21):2591-605. PubMed ID: 8913388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxics compounded sterile preparation control by HPLC during a 16-month assessment in a French university hospital: importance of the mixing bags step.
    Castagne V; Habert H; Abbara C; Rudant E; Bonhomme-Faivre L
    J Oncol Pharm Pract; 2011 Sep; 17(3):191-6. PubMed ID: 20630921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDA inspections find unsafe practices in compounding pharmacies.
    McCarthy M
    BMJ; 2013 Apr; 346():f2414. PubMed ID: 23592476
    [No Abstract]   [Full Text] [Related]  

  • 8. Draft guidelines on quality assurance for pharmacy-prepared sterile products.
    Am J Hosp Pharm; 1992 Feb; 49(2):407-17. PubMed ID: 1554008
    [No Abstract]   [Full Text] [Related]  

  • 9. Recommended guidelines for quality assurance in hospital centralized intravenous admixture services. National Coordinating Committee on Large Volume Parenterals.
    Am J Hosp Pharm; 1980 May; 37(5):645-55. PubMed ID: 7386471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. National survey of quality assurance activities for pharmacy-compounded sterile preparations.
    Morris AM; Schneider PJ; Pedersen CA; Mirtallo JM
    Am J Health Syst Pharm; 2003 Dec; 60(24):2567-76. PubMed ID: 14735774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survey of sterile admixture practices in canadian hospital pharmacies: part 2. More results and discussion.
    Warner T; Nishi C; Checkowski R; Hall KW
    Can J Hosp Pharm; 2009 May; 62(3):192-203. PubMed ID: 22478890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survey of sterile admixture practices in canadian hospital pharmacies: part 1. Methods and results.
    Warner T; Nishi C; Checkowski R; Hall KW
    Can J Hosp Pharm; 2009 Mar; 62(2):100-11. PubMed ID: 22478875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of the aseptic processing environment.
    Frieben WR
    Am J Hosp Pharm; 1983 Nov; 40(11):1928-35. PubMed ID: 6650522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacists' opinions about and compliance with recommendations for intravenous admixture practices.
    Brzozowski DF; Hale KM; Segal R; Mirtallo JM
    Am J Hosp Pharm; 1987 Sep; 44(9):2077-84. PubMed ID: 3479020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Essential elements of quality control.
    Boylan JC
    Am J Hosp Pharm; 1983 Nov; 40(11):1936-9. PubMed ID: 6650523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multistate outbreak of Serratia marcescens bloodstream infection associated with contaminated intravenous magnesium sulfate from a compounding pharmacy.
    Sunenshine RH; Tan ET; Terashita DM; Jensen BJ; Kacica MA; Sickbert-Bennett EE; Noble-Wang JA; Palmieri MJ; Bopp DJ; Jernigan DB; Kazakova S; Bresnitz EA; Tan CG; McDonald LC
    Clin Infect Dis; 2007 Sep; 45(5):527-33. PubMed ID: 17682984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bacteriological quality of air in a ward for sterile pharmaceutical preparations].
    Caorsi P B; Sakurada Z A; Ulloa F MT; Pezzani V M; Latorre O P
    Rev Chilena Infectol; 2011 Feb; 28(1):14-8. PubMed ID: 21526280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Draft guidelines on compounding of nonsterile products in pharmacies. American Society of Hospital Pharmacists.
    Am J Hosp Pharm; 1993 Jul; 50(7):1452-61. PubMed ID: 8362883
    [No Abstract]   [Full Text] [Related]  

  • 19. Prospective survey of parenteral nutrition in Switzerland: a three-year nation-wide survey.
    Pichard C; Mühlebach S; Maisonneuve N; Sierro C
    Clin Nutr; 2001 Aug; 20(4):345-50. PubMed ID: 11478833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compounding USP <797>: inspection, regulation, and oversight of sterile compounding pharmacies.
    Kastango ES
    JPEN J Parenter Enteral Nutr; 2012 Mar; 36(2 Suppl):38S-39S. PubMed ID: 22275322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.